Furthermore, it was found that miR-128-3p may suppress the LIM domain kinase 1 (LIMK1) signaling pathway in BC by targeting the LIM domain kinase 1 (LIMK1) gene (58). The gene discussed is LIMK1; the disease is breast cancer.